BioCryst Pharmaceuticals (BCRX) Institutional Ownership $8.29 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$8.41 +0.13 (+1.51%) As of 05/22/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioCryst Pharmaceuticals (NASDAQ:BCRX)CurrentInstitutional OwnershipPercentage85.88%Number ofInstitutional Buyers(last 12 months)189TotalInstitutional Inflows(last 12 months)$862.50MNumber ofInstitutional Sellers(last 12 months)110TotalInstitutional Outflows(last 12 months)$270.09M Get BCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling BioCryst Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data BCRX Institutional Buying and Selling by Quarter BioCryst Pharmaceuticals Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/19/2026 Bank of America Corp DE5,091,765$48.47M0.0%+231.6%2.003% 5/19/2026 Janus Henderson Group PLC8,908,506$84.85M0.0%+20.3%3.505% 5/18/2026 ADAR1 Capital Management LLC105,000$1M0.1%+133.3%0.041% 5/18/2026 California State Teachers Retirement System258,345$2.46M0.0%+34.7%0.102% 5/18/2026 Royal Bank of Canada18,115$173K0.0%-88.8%0.007% 5/18/2026 Rock Springs Capital Management LP12,600$120K0.0%N/A0.005% 5/18/2026 Elmind Capital LP1,000,000$9.52M2.7%-53.5%0.393% 5/18/2026 Eversept Partners LP3,039,820$28.94M1.5%+1.6%1.196% 5/16/2026 The Manufacturers Life Insurance Company 102,042$971K0.0%+4.5%0.040% 5/16/2026 Quantinno Capital Management LP80,061$762K0.0%+245.8%0.032% Get the Latest News and Ratings for BCRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 5/16/2026 SummitTX Capital L.P.41,165$392K0.0%N/A0.016% 5/16/2026 Lazard Asset Management LLC36,360$346K0.0%-47.8%0.014% 5/16/2026 Orbimed Advisors LLC1,425,200$13.57M0.2%-18.2%0.561% 5/15/2026 Weiss Asset Management LP82,100$782K0.0%N/A0.032% 5/15/2026 Rice Hall James & Associates LLC2,230,105$21.23M1.2%+17.1%0.877% 5/15/2026 Entropy Technologies LP75,908$723K0.0%+34.3%0.030% 5/14/2026 Healthcare of Ontario Pension Plan Trust Fund1,227,040$11.68M0.0%N/A0.483% 5/14/2026 Renaissance Technologies LLC776,990$7.40M0.0%-63.5%0.306% 5/14/2026 Hilltop Holdings Inc.10,310$98K0.0%N/A0.004% 5/14/2026 Caxton Associates LLP20,567$196K0.0%-46.1%0.008% 5/14/2026 Sei Investments Co.150,264$1.43M0.0%+45.7%0.059% 5/14/2026 State of Wyoming103,862$989K0.1%+100.1%0.041% 5/13/2026 Cetera Investment Advisers48,413$461K0.0%+292.6%0.019% 5/13/2026 First Trust Advisors LP800,900$7.63M0.0%+113.6%0.315% 5/7/2026 Dimensional Fund Advisors LP2,690,651$25.62M0.0%+119.0%1.059% 5/7/2026 Swiss National Bank408,668$3.89M0.0%+3.6%0.161% 5/5/2026 Bank of New York Mellon Corp637,658$6.07M0.0%+4.9%0.251% 5/5/2026 IMC Chicago LLC631,290$6.01M0.0%N/A0.248% 5/5/2026 Sanctuary Advisors LLC55,678$530K0.0%-4.9%0.022% 5/5/2026 Hillsdale Investment Management Inc.639,100$6.08M0.2%+14.3%0.252% 5/4/2026 Empirical Financial Services LLC d.b.a. Empirical Wealth Management44,237$421K0.0%+34.4%0.017% 5/4/2026 Principal Financial Group Inc.430,558$4.10M0.0%+14.3%0.169% 5/1/2026 Candriam S.C.A.2,286,841$21.77M0.1%N/A0.900% 4/30/2026 Hsbc Holdings PLC31,499$303K0.0%+30.5%0.012% 4/30/2026 Kestra Advisory Services LLC15,740$150K0.0%+20.5%0.006% 4/30/2026 Personal CFO Solutions LLC21,667$206K0.0%-65.3%0.009% 4/24/2026 Capricorn Fund Managers Ltd202,900$1.93M0.3%N/A0.081% 4/23/2026 Inspire Investing LLC53,879$513K0.0%-10.3%0.021% 4/22/2026 Janney Montgomery Scott LLC163,266$1.55M0.0%+524.8%0.065% 4/22/2026 Pictet Asset Management Holding SA471,573$4.46M0.0%-36.3%0.188% Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock free4/21/2026 Cannon Global Investment Management LLC26,600$253K0.5%N/A0.011% 4/20/2026 RFG Advisory LLC2,870,700$27.33M0.5%N/A1.145% 4/20/2026 OP Asset Management Ltd1,252,863$11.93M0.1%N/A0.500% 4/20/2026 Assenagon Asset Management S.A.232,947$2.22M0.0%-35.2%0.093% 4/16/2026 SG Americas Securities LLC20,649$197K0.0%-83.7%0.008% 3/20/2026 Hsbc Holdings PLC24,133$188K0.0%-61.0%0.010% 3/17/2026 Rockefeller Capital Management L.P.26,797$209K0.0%+403.2%0.011% 2/19/2026 Invesco Ltd.1,354,897$10.57M0.0%+40.8%0.643% 2/18/2026 Mackenzie Financial Corp150,728$1.15M0.0%+16.6%0.072% 2/18/2026 NewEdge Advisors LLC50,041$390K0.0%N/A0.024% 2/18/2026 XTX Topco Ltd17,111$133K0.0%N/A0.008% 2/18/2026 Voloridge Investment Management LLC449,743$3.51M0.0%-53.0%0.213% 2/18/2026 Vestal Point Capital LP2,250,000$17.55M0.6%N/A1.068% 2/18/2026 Virtus Investment Advisers LLC90,278$704K0.2%+111.3%0.043% 2/18/2026 Wellington Management Group LLP86,520$675K0.0%-7.5%0.041% 2/18/2026 Susquehanna Portfolio Strategies LLC778,521$6.07M0.1%N/A0.369% 2/18/2026 Tudor Investment Corp ET AL114,541$893K0.0%+16.7%0.054% 2/18/2026 Twinbeech Capital LP23,700$185K0.0%-87.9%0.011% 2/18/2026 Sphera Funds Management LTD.837,889$6.54M1.2%N/A0.398% 2/18/2026 Quantessence Capital LLC13,200$103K1.2%N/A0.006% 2/18/2026 Orbimed Advisors LLC1,741,800$13.59M0.3%+93.2%0.827% 2/18/2026 Perceptive Advisors LLC3,162,529$24.67M0.4%N/A1.501% 2/18/2026 Millennium Management LLC137,626$1.07M0.0%-70.1%0.065% 2/18/2026 Man Group plc407,850$3.18M0.0%+15.1%0.194% 2/18/2026 Ishara Investments LP300,000$2.34M2.7%N/A0.142% 2/18/2026 Janus Henderson Group PLC7,404,386$57.79M0.0%+7,807.2%3.514% 2/18/2026 Gotham Asset Management LLC216,946$1.69M0.0%-36.9%0.103% 2/18/2026 Elmind Capital LP2,150,000$16.77M4.9%N/A1.020% 2/18/2026 Engineers Gate Manager LP224,543$1.75M0.0%-49.3%0.107% 2/18/2026 Eversept Partners LP2,992,895$23.35M1.2%+117.9%1.420% 2/18/2026 Baker BROS. Advisors LP2,822,727$22.02M0.1%N/A1.339% 2/18/2026 Banco Bilbao Vizcaya Argentaria S.A.19,249$148K0.0%N/A0.009% 2/17/2026 ADAR1 Capital Management LLC45,000$351K0.0%N/A0.021% 2/17/2026 Schonfeld Strategic Advisors LLC141,449$1.10M0.0%-15.2%0.067% 2/17/2026 AQR Capital Management LLC704,291$5.49M0.0%-29.6%0.334% 2/17/2026 Cetera Investment Advisers12,330$96K0.0%+13.8%0.006% 2/17/2026 Abel Hall LLC24,898$194K0.0%N/A0.012% 2/17/2026 Lazard Asset Management LLC69,598$543K0.0%+30.6%0.033% 2/17/2026 Jain Global LLC74,455$581K0.0%N/A0.035% 2/17/2026 RA Capital Management L.P.15,827,186$123.45M1.3%N/A7.510% 2/17/2026 Jump Financial LLC910,930$7.11M0.1%-1.5%0.432% 2/17/2026 Price T Rowe Associates Inc. MD177,392$1.38M0.0%+9.9%0.084% 2/17/2026 Vinva Investment Management Ltd18,733$146K0.0%-64.7%0.009% 2/17/2026 Osaic Holdings Inc.82,766$646K0.0%+34.0%0.039% 2/17/2026 Integral Health Asset Management LLC200,000$1.56M0.1%N/A0.095% 2/17/2026 California State Teachers Retirement System191,847$1.50M0.0%+5.1%0.091% 2/17/2026 Diadema Partners LP190,928$1.49M0.3%N/A0.091% 2/17/2026 Russell Investments Group Ltd.229,226$1.79M0.0%-27.1%0.109% 2/17/2026 State of Wisconsin Investment Board347,190$2.71M0.0%-7.6%0.165% 2/17/2026 Captrust Financial Advisors17,740$138K0.0%-9.4%0.008% Before you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listing2/17/2026 Royal Bank of Canada161,456$1.26M0.0%-12.9%0.077% 2/17/2026 Graham Capital Management L.P.83,876$654K0.0%-68.7%0.040% 2/17/2026 Persistent Asset Partners Ltd51,701$403K0.2%N/A0.025% 2/17/2026 Rice Hall James & Associates LLC1,904,146$14.85M0.8%+1.3%0.904% 2/17/2026 University of Texas Texas AM Investment Management Co.64,507$503K0.1%N/A0.031% 2/16/2026 Squarepoint Ops LLC1,659,192$12.94M0.0%+49.7%0.787% 2/16/2026 Panagora Asset Management Inc.88,876$693K0.0%-28.2%0.042% 2/16/2026 Mariner LLC31,495$246K0.0%+60.0%0.015% 2/16/2026 Entropy Technologies LP56,517$441K0.0%-16.3%0.027% 2/16/2026 Barclays PLC726,367$5.67M0.0%-7.1%0.345% BCRX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCRX shares? During the previous two years, 307 institutional investors and hedge funds held shares of BioCryst Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($173.73M), RA Capital Management L.P. ($123.45M), Deerfield Management Company L.P. ($92.36M), State Street Corp ($86.37M), Janus Henderson Group PLC ($84.85M), Deerfield Management Company L.P. Series C ($61.25M), and Bank of America Corp DE ($48.47M).Learn more on BioCryst Pharmaceuticals' institutional investors. What percentage of BioCryst Pharmaceuticals' stock is owned by institutional investors? 85.88% of BioCryst Pharmaceuticals' stock is owned by institutional investors. Learn more on BCRX's institutional investor holdings. Which institutional investors have been buying BioCryst Pharmaceuticals' stock? Of the 267 institutional investors that purchased BioCryst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($15.83M), Janus Henderson Group PLC ($8.81M), Deerfield Management Company L.P. ($7.48M), Arrowstreet Capital Limited Partnership ($5.03M), Bank of America Corp DE ($4.96M), Assenagon Asset Management S.A. ($3.61M), and Vanguard Group Inc. ($3.31M). How much institutional buying is happening at BioCryst Pharmaceuticals? Institutional investors have bought a total of 104,058,002 shares in the last 24 months. This purchase volume represents approximately $862.50M in transactions. Which of BioCryst Pharmaceuticals' major shareholders have been selling company stock? Of the 110 institutional investors that sold BioCryst Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($3.39M), Avoro Capital Advisors LLC ($3.25M), Voloridge Investment Management LLC ($2.02M), Millennium Management LLC ($1.87M), Alkeon Capital Management LLC ($1.75M), Ameriprise Financial Inc. ($1.64M), and Renaissance Technologies LLC ($1.36M). How much institutional selling is happening at BioCryst Pharmaceuticals? Institutional investors have sold a total of 33,206,596 shares in the last 24 months. This volume of shares sold represents approximately $270.09M in transactions. Related Companies HALO Institutional Ownership ALKS Institutional Ownership RGEN Institutional Ownership LGND Institutional Ownership CLDX Institutional Ownership INVA Institutional Ownership NVAX Institutional Ownership ZBIO Institutional Ownership LXRX Institutional Ownership MNKD Institutional Ownership This page (NASDAQ:BCRX) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCryst Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCryst Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
